RNTX · Forms 3, 4, 5
Insider trades at Rein Therapeutics, Inc.
No open-market insider buys or sells at Rein Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Rein Therapeutics, Inc. (RNTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Rein Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rickenbach Josef H Von | Director | Buy | 4,500 | $1.07 | $5K | Form 4 | |
| Rickenbach Josef H Von | Director | Buy | 23,190 | $1.06 | $24K | Form 4 | |
| Rickenbach Josef H Von | Director | Buy | 15,950 | $1.05 | $17K | Form 4 | |
| Rickenbach Josef H Von | Director | Buy | 3,420 | $1.04 | $4K | Form 4 | |
| James Brian Windsor | Director | Buy | 25,000 | $1.00 | $25K | Form 4 | |
| Voss Capital, LP | 10% owner | Buy | 104,183 | $1.22 | $128K | Form 4 | |
| Voss Capital, LP | 10% owner | Buy | 178,392 | $1.39 | $248K | Form 4 | |
| Voss Capital, LP | 10% owner | Buy | 92,642 | $1.37 | $127K | Form 4 | |
| Voss Capital, LP | 10% owner | Buy | 4,840 | $1.37 | $7K | Form 4 | |
| Voss Capital, LP | 10% owner | Buy | 30,176 | $1.39 | $42K | Form 4 | |
| Voss Capital, LP | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Manuel Aivado | Director | Options or other derivatives | Form 4 | ||||
| Rickenbach Josef H Von | Director | Options or other derivatives | Form 4 | ||||
| Alan A Musso | Director | Options or other derivatives | Form 4 | ||||
| William Fairey | Director | Options or other derivatives | Form 4 | ||||
| Reinhard J. Ambros | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.